California Attorney General Rob Bonta has taken legal action against two anti-abortion organizations, Heartbeat International (HBI) and RealOptions Obria, for making unsupported claims about reversing the effects of the abortion pill mifepristone.
In a complaint filed in Alameda County Superior Court, Bonta accused the organizations of violating state laws against fraudulent business practices.
While the lawsuit seeks a court order to prevent the defendants from advertising abortion pill reversal, Reuters noted, it does not aim to prohibit the practice.
HBI, in response to the lawsuit, mentioned that it had not yet been served with legal documents and argued that women who regret taking mifepristone "deserve the right to try and save their pregnancies."
Advocates of medication abortion reversal argue that administering a high dose of progesterone can counteract mifepristone's effects.
However, it's essential to note that the only clinical trial conducted on this process was prematurely halted after three out of 12 patients experienced severe bleeding, necessitating hospitalization.
This legal action in California follows similar developments in other states. Colorado recently banned medication abortion reversal treatment, while Kansas passed a law mandating that healthcare providers inform patients about the possibility of abortion pill reversal, a measure currently being contested by Planned Parenthood.
Additionally, a Texas judge suspended federal approval for mifepristone earlier this year, pending an appeal to the U.S. Supreme Court by anti-abortion activists.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
